Need professional-grade analysis? Visit stockanalysis.com
$33.48B
N/A
464
N/A
Shanghai MicroPort MedBot Group Co Ltd (2252) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at HKD34.14, down 1.56% from the previous close.
Over the past year, 2252 has traded between a low of HKD14.94 and a high of HKD34.68. The stock has gained 103.0% over this period. It is currently 128.5% above its 52-week low.
Shanghai MicroPort MedBot Group Co Ltd has a market capitalization of $33.48B.
Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, design, manufacture, and sale of surgical robots in the People's Republic of China. The company offers Toumai, a laparoscopic surgical robot for use in urologic, gynecologic, thoracic, and general surgeries; DFVision, a 3D electronic laparoscope, which is used in laparoscopic surgeries for abdominal, thoracic, and pelvic organs; SkyWalker, an orthopedic surgical robot for knee arthroplasty and hip arthroplasty; R-One, a vascular interventional surgical robot for coronary angioplasty; and iSR'obot, a Mona Lisa robotic transperineal prostate biopsy system. It also offers trans-bronchial surgical robots for trans-bronchial diagnosis and treatment. In addition, the company is involved in the manufacture of parts of surgical robot devices; research, development, assembly, and distribution of surgical robot devices; and research and development of system, as well as investment activities. The company was founded in 2014 and is headquartered in Shanghai, China. Shanghai MicroPort MedBot (Group) Co., Ltd. operates as a subsidiary of Shanghai Latent Artificial Intelligence Co., Ltd.
Side-by-side comparison against top Healthcare peers.